IGG4-RELATED DISEASE
Clinical trials for IGG4-RELATED DISEASE explained in plain language.
Never miss a new study
Get alerted when new IGG4-RELATED DISEASE trials appear
Sign up with your email to follow new studies for IGG4-RELATED DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill aims to tame rare inflammatory disease
Disease control Recruiting nowThis phase 3 study tests whether the oral drug rilzabrutinib can prevent disease flares in adults with active IgG4-related disease, a rare condition causing swelling and organ damage. About 124 participants will receive either rilzabrutinib or a placebo for 52 weeks, alongside st…
Matched conditions: IGG4-RELATED DISEASE
Phase: PHASE3 • Sponsor: Sanofi • Aim: Disease control
Last updated Jul 02, 2026 06:00 UTC
-
Old drug, new hope: could filgotinib tame rare immune diseases?
Disease control Recruiting nowThis phase 2 trial is testing whether filgotinib, a drug already used for arthritis, can help people with three rare immune diseases: Behçet's disease, myositis, and IgG4-related disease. The goal is to see if it can control disease activity and reduce the need for long-term ster…
Matched conditions: IGG4-RELATED DISEASE
Phase: PHASE2 • Sponsor: UMC Utrecht • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New hope for IgG4 patients: which drug combo works best?
Disease control Recruiting nowThis study tests two treatment plans for people with IgG4-related disease affecting superficial organs like glands or skin. One group gets prednisone plus iguratimod, the other gets prednisone plus leflunomide. Over 12 months, researchers will track how many patients have a relap…
Matched conditions: IGG4-RELATED DISEASE
Phase: NA • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New cell therapy trial aims to tame rare autoimmune disease
Disease control Recruiting nowThis early-stage trial tests a new treatment called ACE1831 for people with IgG4-related disease, a rare condition where the immune system attacks the body, causing swelling and organ damage. ACE1831 is made from healthy donor cells and given as an infusion. The study will check …
Matched conditions: IGG4-RELATED DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Acepodia Biotech, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New drug aims to shrink swollen glands in rare disease
Disease control Recruiting nowThis study tests whether efgartigimod, a drug that lowers certain antibodies, can reduce swelling in the tear glands, saliva glands, or pancreas of people with IgG4-related disease. Five adults will receive weekly injections for 12 weeks and have regular scans and checkups. The g…
Matched conditions: IGG4-RELATED DISEASE
Phase: PHASE2 • Sponsor: Stanford University • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New drug combo aims to tame rare inflammatory disease
Disease control Recruiting nowThis study tests whether adding lenalidomide to standard steroid treatment can better control active IgG4-related disease (IgG4-RD), a rare condition that causes swelling and damage in organs. About 198 adults will receive either lenalidomide plus prednisone or prednisone alone f…
Matched conditions: IGG4-RELATED DISEASE
Phase: PHASE2, PHASE3 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Experimental CAR-T therapy targets stubborn autoimmune disease
Disease control Recruiting nowThis Phase 2 trial tests a personalized cell therapy called anti-BCMA-CD19 CAR-T cells in 9 adults with IgG4-related disease that hasn't responded to standard treatments. Participants receive an infusion of their own modified immune cells after a short course of chemotherapy. The…
Matched conditions: IGG4-RELATED DISEASE
Phase: PHASE2 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Jun 26, 2026 12:38 UTC
-
New scan could shine a light on hidden inflammation
Diagnosis Recruiting nowThis study is testing a new radioactive tracer called [18F]AlF-FAPI-74 for PET/CT scans to see if it can find inflammation better than the current standard tracer. The trial will involve 140 people with fever of unknown origin, IgG4-related disease, or axial spondylarthritis. Res…
Matched conditions: IGG4-RELATED DISEASE
Phase: PHASE2, PHASE3 • Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Diagnosis
Last updated Jun 27, 2026 12:09 UTC